Search research articles
Contact Us
Filters
Showing results (161-170 of 295) with videos related to
Page
of 30
Sort By:
British Journal of Cancer
|
March 23, 2016
Prognostic role of ERBB2, MET and VEGFA expression in metastatic colorectal cancer patients treated with anti-EGFR antibodies
Naoki Takahashi, Satoru Iwasa, Hirokazu Taniguchi, et al.
International Journal of Clinical Oncology
|
October 27, 2009
Current therapeutic strategies for anal squamous cell carcinoma in Japan
Atsuo Takashima, Yasuhiro Shimada, Tetsuya Hamaguchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 31, 2002
Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205)
Atsushi Ohtsu, Yasuhiro Shimada, Kuniaki Shirao, et al.
Anticancer Research
|
June 30, 2016
Comparison of Panitumumab Plus Irinotecan and Cetuximab Plus Irinotecan for KRAS Wild-type Metastatic Colorectal Cancer
Toshifumi Yamaguchi, Satoru Iwasa, Kengo Nagashima, et al.
Japanese Journal of Clinical Oncology
|
November 6, 2020
Second primary cancers and recurrence in patients after resection of colorectal cancer: An integrated analysis of trials by Japan Clinical Oncology Group: JCOG1702A
Kiyo Tanaka, Gakuto Ogawa, Junki Mizusawa, et al.
Japanese Journal of Clinical Oncology
|
October 10, 2009
Pfetin as a prognostic biomarker in gastrointestinal stromal tumor: novel monoclonal antibody and external validation study in multiple clinical facilities
Kazutaka Kikuta, Masahiro Gotoh, Tatsuo Kanda, et al.
BMC Research Notes
|
April 30, 2014
Clinicopathological features and prognostic roles of KRAS, BRAF, PIK3CA and NRAS mutations in advanced gastric cancer
Naoki Takahashi, Yasuhide Yamada, Hirokazu Taniguchi, et al.
Japanese Journal of Clinical Oncology
|
November 9, 2012
A double-blind, placebo-controlled study of the safety and efficacy of vitamin K1 ointment for the treatment of patients with cetuximab-induced acneiform eruption
Hironobu Hashimoto, Satoru Iwasa, Takako Yanai, et al.
Japanese Journal of Clinical Oncology
|
June 23, 2012
Validation study on pfetin and ATP-dependent RNA helicase DDX39 as prognostic biomarkers in gastrointestinal stromal tumour
Daisuke Kubota, Taketo Okubo, Tsuyoshi Saito, et al.
Japanese Journal of Clinical Oncology
|
September 10, 2011
Pfetin as a prognostic biomarker for gastrointestinal stromal tumor: validation study in multiple clinical facilities
Daisuke Kubota, Hajime Orita, Akihiko Yoshida, et al.
Page
of 30
Search research articles
Search
Showing results (161-170 of 295) with videos related to
Sort By:
Page
of 30
British Journal of Cancer
|
March 23, 2016
Prognostic role of ERBB2, MET and VEGFA expression in metastatic colorectal cancer patients treated with anti-EGFR antibodies
Naoki Takahashi, Satoru Iwasa, Hirokazu Taniguchi, et al.
International Journal of Clinical Oncology
|
October 27, 2009
Current therapeutic strategies for anal squamous cell carcinoma in Japan
Atsuo Takashima, Yasuhiro Shimada, Tetsuya Hamaguchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 31, 2002
Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205)
Atsushi Ohtsu, Yasuhiro Shimada, Kuniaki Shirao, et al.
Anticancer Research
|
June 30, 2016
Comparison of Panitumumab Plus Irinotecan and Cetuximab Plus Irinotecan for KRAS Wild-type Metastatic Colorectal Cancer
Toshifumi Yamaguchi, Satoru Iwasa, Kengo Nagashima, et al.
Japanese Journal of Clinical Oncology
|
November 6, 2020
Second primary cancers and recurrence in patients after resection of colorectal cancer: An integrated analysis of trials by Japan Clinical Oncology Group: JCOG1702A
Kiyo Tanaka, Gakuto Ogawa, Junki Mizusawa, et al.
Japanese Journal of Clinical Oncology
|
October 10, 2009
Pfetin as a prognostic biomarker in gastrointestinal stromal tumor: novel monoclonal antibody and external validation study in multiple clinical facilities
Kazutaka Kikuta, Masahiro Gotoh, Tatsuo Kanda, et al.
BMC Research Notes
|
April 30, 2014
Clinicopathological features and prognostic roles of KRAS, BRAF, PIK3CA and NRAS mutations in advanced gastric cancer
Naoki Takahashi, Yasuhide Yamada, Hirokazu Taniguchi, et al.
Japanese Journal of Clinical Oncology
|
November 9, 2012
A double-blind, placebo-controlled study of the safety and efficacy of vitamin K1 ointment for the treatment of patients with cetuximab-induced acneiform eruption
Hironobu Hashimoto, Satoru Iwasa, Takako Yanai, et al.
Japanese Journal of Clinical Oncology
|
June 23, 2012
Validation study on pfetin and ATP-dependent RNA helicase DDX39 as prognostic biomarkers in gastrointestinal stromal tumour
Daisuke Kubota, Taketo Okubo, Tsuyoshi Saito, et al.
Japanese Journal of Clinical Oncology
|
September 10, 2011
Pfetin as a prognostic biomarker for gastrointestinal stromal tumor: validation study in multiple clinical facilities
Daisuke Kubota, Hajime Orita, Akihiko Yoshida, et al.
Page
of 30